Profusa, Inc.
Close on Oct 19, 2026
- Market cap
- $51.92K
- P/E (TTM)
- –
- Dividend yield
- –
Earnings
Quarterly results announced on Form 8-K, Item 2.02
| Quarter | Reported | Time | Revenue | EPS (GAAP) | EPS (adjusted) |
|---|---|---|---|---|---|
| Q2 FY2026 Ended Jun 30, 2026 | Aug 20, 2026 | Before market open | – | – | – |
Press releases
Announcements Profusa filed with the SEC
PRESS RELEASE DATED SEPTEMBER 14, 2026
Other events · EX-99.1 to Form 8-K
Profusa Announces Q2 2026 Financial Results and Progress on the
Results of operations · EX-99.1 to Form 8-K
Announces 1-for-4 Reverse Stock Split
Charter or bylaw amendment · Other events · EX-99.1 to Form 8-K
PRESS RELEASE ISSUED ON JULY 31, 2026
Material agreement · Unregistered share sale · Charter or bylaw amendment · Regulation FD disclosure · Other events · EX-99.1 to Form 8-K
PRESS RELEASE DATED JULY 27, 2026
Executive or director change · Regulation FD disclosure · Other events · EX-99.1 to Form 8-K
PRESS RELEASE DATED JULY 2, 2026
Charter or bylaw amendment · Other events · EX-99.1 to Form 8-K
Profusa Announces Listing Transfer to The Nasdaq
Other events · EX-99.1 to Form 8-K
Profusa Receives Favorable Nasdaq Listing Determination
Other events · EX-99.1 to Form 8-K
EX-99.1 to Form 8-K
Material agreement · New financial obligation · Unregistered share sale · Other events · EX-99.1 to Form 8-K
Profusa Expands into Multi-Billion Dollar Precision
Material agreement · New financial obligation · Unregistered share sale · Other events · EX-99.2 to Form 8-K
Profusa and Mayo Clinic collaborate to Advance High-Impact Clinical
Material agreement · Other events · EX-99.1 to Form 8-K
PRESS RELEASE DATED FEBRUARY 5, 2026
Charter or bylaw amendment · Other events · EX-99.1 to Form 8-K
PRESS RELEASE, DATED NOVEMBER 19, 2025
Other events · EX-99.1 to Form 8-K
PRESS RELEASE, DATED OCTOBER 30, 2025
Regulation FD disclosure · EX-99.1 to Form 8-K
INVESTOR PRESENTATION, DATED OCTOBER 2025
Regulation FD disclosure · EX-99.2 to Form 8-K
INVESTOR PRESENTATION, DATED OCTOBER 2025
Regulation FD disclosure · EX-99.1 to Form 8-K
Invests Additional $1 Million in Digital Treasury Assets
Material agreement · Charter or bylaw amendment · Other events · EX-99.1 to Form 8-K
PRESS RELEASE, DATED AS OF AUGUST 19, 2025
Other events · EX-99.1 to Form 8-K
LETTER TO SHAREHOLDERS, DATED AS OF AUGUST 6, 2025
Other events · EX-99.1 to Form 8-K
PRESS RELEASE BY NORTHVIEW AND PROFUSA, DATED AS OF JULY 11, 2025
Material agreement · Acquisition or disposition completed · New financial obligation · Unregistered share sale · Executive or director change · Other events · EX-99.1 to Form 8-K
UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS OF PROFUSA AS OF MARCH 31, 2025 AND FOR THE THREE MONTHS ENDED MARCH 31, 2025 AND 2024
Material agreement · Acquisition or disposition completed · New financial obligation · Unregistered share sale · Executive or director change · Other events · EX-99.2 to Form 8-K
UNAUDITED PRO FORMA CONDENSED COMBINED BALANCE SHEET AND STATEMENTS OF OPERATIONS OF THE COMPANY AS OF MARCH 31, 2025 AND FOR THE THREE MONTH PERIOD ENDED MARCH 31, 2025
Material agreement · Acquisition or disposition completed · New financial obligation · Unregistered share sale · Executive or director change · Other events · EX-99.3 to Form 8-K
PRESS RELEASE DATED DECEMBER 26, 2024
Listing notice · Other events · EX-99.1 to Form 8-K
PRESS RELEASE DATED DECEMBER 11, 2024
Listing notice · Other events · EX-99.1 to Form 8-K
PRESS RELEASE DATED NOVEMBER 7, 2022
Material agreement · Regulation FD disclosure · EX-99.1 to Form 8-K
INVESTOR PRESENTATION DATED NOVEMBER 2022
Material agreement · Regulation FD disclosure · EX-99.2 to Form 8-K
PRESS RELEASE DATED JANUARY 19, 2022
Other events · EX-99.1 to Form 8-K
AUDITED BALANCE SHEET AS OF DECEMBER 22, 2021
Other events · EX-99.1 to Form 8-K
PRESS RELEASE, DATED DECEMBER 20, 2021
Material agreement · Unregistered share sale · Executive or director change · Charter or bylaw amendment · Other events · EX-99.1 to Form 8-K